Descripción del proyecto
Diagnósticos y tratamientos de precisión gracias a los avances en nanomedicina
La nanotecnología tiene múltiples aplicaciones en el sector biomédico, desde el diagnóstico hasta la administración de fármacos y el seguimiento de tratamientos. Los nanomateriales ofrecen soluciones precisas y específicas, que mejoran los tratamientos y posibilitan detectar antes y con una gran exactitud las enfermedades. En el proyecto LungCare, financiado por las acciones Marie Skłodowska-Curie, se empleará la nanotecnología para desarrollar nanovacunas e inhaloterapias contra las infecciones pulmonares provocadas por «Pseudomonas aeruginosa». Sus investigadores también desarrollarán sensores de diagnóstico para el análisis del cáncer de pulmón, así como pruebas portátiles para la detección temprana de la tuberculosis. Este proyecto es una iniciativa de colaboración con socios de la unión Europea y de países asociados, que fomenta el intercambio de conocimientos y respalda una investigación de alto nivel.
Objetivo
Nanotechnology concepts have integrated into almost all aspects of current research and the present research area is recognised to be one of nanoscience. Nanomaterials are promising materials to develop new technologies in every branch of science and technology. This is also true when it comes to the biomedical field, where nanotechnology in the form of nanomedicine has a great potential to overcome some of the current limitations using conventional analytical and therapeutic approaches. The focal point of the LungCare project is to turn nanotechnological potentials into tangible outcomes with benefits for patients and the society at large. The philosophy behind LungCare is to provide improvement to the treatment of Pseudomonas aeruginosa (PA) infections via nanovaccines and inhalable therapeutics. It focuses also on the pending question for early and accurate diagnostics of tuberculosis (TB) and lung cancer via the development of sensitive point of care testing devices. In case of lung cancer, sensor development will be accompanied by quantitative image analysis to increase diagnostic accuracy and improve our understanding of the disease characteristics. The LungCare project aims at training of the next generation of students in this rapidly advancing field at the interface between chemistry-physics-biology-medicine and to up-date and improve the know-how of senior researchers and PIs in important parts of nanomedicine such as clinical assay development, state-of the art of organoid developments to limit in vivo testing via and the implementation of artificial intelligent in diagnostics. The different intersectoral secondments to 2 European countries (France, Austria), 2 associated countries (Turkey, Ukraine) and one associated partner (Argentina) will strengthen nanomedicine on the EU level, will encourage knowledge gain and will insure preserving high level research activities under the EU umbrella.
Ámbito científico
Palabras clave
Programa(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Régimen de financiación
HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff ExchangesCoordinador
75794 Paris
Francia